Hollsteen
← Alphabet

SG&A

Flow – sum over the period · $B

QuartersFiscal years

$BSG&A · Q1 2016: $3.9B · derived · 10-Q 0001652044-16-000021 filed May 3, 2016SG&A · Q2 2016: $4.0B · derived · 10-Q 0001652044-16-000032 filed Aug 4, 2016SG&A · Q3 2016: $4.4B · derived · 10-Q 0001652044-16-000038 filed Nov 3, 2016SG&A · Q4 2016: $5.1B · derived · 10-K 0001652044-18-000007 filed Feb 6, 2018SG&A · Q1 2017: $4.4B · derived · 10-Q 0001652044-17-000014 filed May 2, 2017SG&A · Q2 2017: $4.6B · derived · 10-Q 0001652044-17-000026 filed Jul 25, 2017SG&A · Q3 2017: $4.6B · derived · 10-Q 0001652044-17-000042 filed Oct 27, 2017SG&A · Q4 2017: $6.1B · derived · 10-K 0001652044-19-000004 filed Feb 5, 2019SG&A · Q1 2018: $5.0B · derived · 10-Q 0001652044-18-000016 filed Apr 24, 2018SG&A · Q2 2018: $5.5B · derived · 10-Q 0001652044-18-000027 filed Jul 24, 2018SG&A · Q3 2018: $5.6B · derived · 10-Q 0001652044-18-000035 filed Oct 26, 2018SG&A · Q4 2018: $7.1B · derived · 10-K 0001652044-20-000008 filed Feb 4, 2020SG&A · Q1 2019: $6.0B · derived · 10-Q 0001652044-19-000015 filed Apr 30, 2019SG&A · Q2 2019: $6.3B · derived · 10-Q 0001652044-19-000023 filed Jul 26, 2019SG&A · Q3 2019: $7.2B · derived · 10-Q 0001652044-19-000032 filed Oct 29, 2019SG&A · Q4 2019: $8.6B · derived · 10-K 0001652044-21-000010 filed Feb 3, 2021SG&A · Q1 2020: $7.4B · derived · 10-Q 0001652044-20-000021 filed Apr 29, 2020SG&A · Q2 2020: $6.5B · derived · 10-Q 0001652044-20-000032 filed Jul 31, 2020SG&A · Q3 2020: $7.0B · derived · 10-Q 0001652044-20-000050 filed Oct 30, 2020SG&A · Q4 2020: $8.1B · derived · 10-K 0001652044-22-000019 filed Feb 2, 2022SG&A · Q1 2021: $7.3B · derived · 10-Q 0001652044-21-000020 filed Apr 28, 2021SG&A · Q2 2021: $8.6B · derived · 10-Q 0001652044-21-000047 filed Jul 28, 2021SG&A · Q3 2021: $8.8B · derived · 10-Q 0001652044-21-000057 filed Oct 27, 2021SG&A · Q4 2021: $11.7B · derived · 10-K 0001652044-23-000016 filed Feb 3, 2023SG&A · Q1 2022: $9.2B · derived · 10-Q 0001652044-22-000029 filed Apr 27, 2022SG&A · Q2 2022: $10.3B · derived · 10-Q 0001652044-22-000071 filed Jul 27, 2022SG&A · Q3 2022: $10.5B · derived · 10-Q 0001652044-22-000090 filed Oct 26, 2022SG&A · Q4 2022: $12.3B · derived · 10-K 0001652044-24-000022 filed Jan 31, 2024SG&A · Q1 2023: $10.3B · derived · 10-Q 0001652044-23-000045 filed Apr 26, 2023SG&A · Q2 2023: $10.3B · derived · 10-Q 0001652044-23-000070 filed Jul 26, 2023SG&A · Q3 2023: $10.9B · derived · 10-Q 0001652044-23-000094 filed Oct 25, 2023SG&A · Q4 2023: $12.9B · derived · 10-K 0001652044-25-000014 filed Feb 5, 2025SG&A · Q1 2024: $9.5B · derived · 10-Q 0001652044-24-000053 filed Apr 26, 2024SG&A · Q2 2024: $9.9B · derived · 10-Q 0001652044-24-000079 filed Jul 24, 2024SG&A · Q3 2024: $10.8B · derived · 10-Q 0001652044-24-000118 filed Oct 30, 2024SG&A · Q4 2024: $11.8B · derived · 10-K 0001652044-26-000018 filed Feb 5, 2026SG&A · Q1 2025: $9.7B · derived · 10-Q 0001652044-25-000043 filed Apr 25, 2025SG&A · Q2 2025: $12.3B · derived · 10-Q 0001652044-25-000062 filed Jul 24, 2025SG&A · Q3 2025: $14.6B · derived · 10-Q 0001652044-25-000091 filed Oct 30, 2025SG&A · Q4 2025: $13.6B · derived · 10-K 0001652044-26-000018 filed Feb 5, 2026SG&A · Q1 2026: $11.9B · derived · 10-Q 0001652044-26-000048 filed Apr 30, 2026SG&A · Q2 2026: $14.9B · derived · 10-Q 0001652044-26-000071 filed Jul 23, 202614.6a14.9a3.9aQ1 2016Q2 2026
$BSG&A · Q3 2024: $10.8B · derived · 10-Q 0001652044-24-000118 filed Oct 30, 2024SG&A · Q4 2024: $11.8B · derived · 10-K 0001652044-26-000018 filed Feb 5, 2026SG&A · Q1 2025: $9.7B · derived · 10-Q 0001652044-25-000043 filed Apr 25, 2025SG&A · Q2 2025: $12.3B · derived · 10-Q 0001652044-25-000062 filed Jul 24, 2025SG&A · Q3 2025: $14.6B · derived · 10-Q 0001652044-25-000091 filed Oct 30, 2025SG&A · Q4 2025: $13.6B · derived · 10-K 0001652044-26-000018 filed Feb 5, 2026SG&A · Q1 2026: $11.9B · derived · 10-Q 0001652044-26-000048 filed Apr 30, 2026SG&A · Q2 2026: $14.9B · derived · 10-Q 0001652044-26-000071 filed Jul 23, 202614.6a14.9a10.8aQ3 2024Q2 2026Q3 2025
Q3 2025
14.6a$B
derived
All values (42)
PeriodValue ($B)Status
Q2 202614.9derived
Q1 202611.9derived
Q4 202513.6derived
Q3 202514.6derived
Q2 202512.3derived
Q1 20259.7derived
Q4 202411.8derived
Q3 202410.8derived
Q2 20249.9derived
Q1 20249.5derived
Q4 202312.9derived
Q3 202310.9derived
Q2 202310.3derived
Q1 202310.3derived
Q4 202212.3derived
Q3 202210.5derived
Q2 202210.3derived
Q1 20229.2derived
Q4 202111.7derived
Q3 20218.8derived
Q2 20218.6derived
Q1 20217.3derived
Q4 20208.1derived
Q3 20207.0derived
Q2 20206.5derived
Q1 20207.4derived
Q4 20198.6derived
Q3 20197.2derived
Q2 20196.3derived
Q1 20196.0derived
Q4 20187.1derived
Q3 20185.6derived
Q2 20185.5derived
Q1 20185.0derived
Q4 20176.1derived
Q3 20174.6derived
Q2 20174.6derived
Q1 20174.4derived
Q4 20165.1derived
Q3 20164.4derived
Q2 20164.0derived
Q1 20163.9derived

CSV with all sources · Technical ID: sga

More metrics for Alphabet

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$14.6B (derived)
Period
Q3 2025, ended Sep 30, 2025 · quarterly value (3 months, not cumulative)
Calculation
sga = Sales & marketing 7,205M + G&A 7,393M = $14.6B (Summanden: berichtete SEC-Werte derselben Periode)
Source
10-Q, filed Oct 30, 2025 · 0001652044-25-000091
Location
sga = + sm + ga
Confidence
0.95 – berechnet aus berichteten SEC-Werten derselben Periode (e.g. SG&A = S&M + G&A)

Versions

v1$14.6BOct 30, 202510-Q 0001652044-25-000091derived · confidence 0.95 · current